Lynx1 Capital Management as of Sept. 30, 2022
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 12 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bellus Health Com New | 22.7 | $25M | 2.4M | 10.56 | |
| Alpine Immune Sciences (ALPN) | 19.8 | $22M | 3.1M | 7.20 | |
| Kinnate Biopharma (KNTE) | 18.1 | $20M | 1.7M | 11.95 | |
| Merus N V (MRUS) | 11.1 | $12M | 613k | 20.03 | |
| Cymabay Therapeutics | 7.3 | $8.1M | 2.3M | 3.50 | |
| Aerovate Therapeutics (AVTE) | 4.1 | $4.6M | 276k | 16.58 | |
| Pardes Biosciences | 3.8 | $4.2M | 2.3M | 1.85 | |
| Pieris Pharmaceuticals (PIRS) | 3.6 | $4.0M | 3.5M | 1.15 | |
| Passage Bio (PASG) | 3.1 | $3.4M | 2.8M | 1.25 | |
| Immunic (IMUX) | 3.1 | $3.4M | 1.1M | 3.16 | |
| Theseus Pharmaceuticals | 2.6 | $2.9M | 505k | 5.80 | |
| Otonomy | 0.6 | $682k | 2.3M | 0.29 |
